Dr. Sherry Yafai, M.D

NPI: 1366628471
Total Payments
$6,088
2024 Payments
$375.08
Companies
8
Transactions
15
Medicare Patients
225
Medicare Billing
$16,619

Payment Breakdown by Category

Consulting$5,000 (82.1%)
Food & Beverage$1,088 (17.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $5,000 1 82.1%
Food and Beverage $1,088 14 17.9%

Top Paying Companies

Company Total Records Latest Year
Merck Sharp & Dohme LLC $5,231 3 $0 (2023)
Amgen Inc. $277.95 3 $0 (2024)
Novo Nordisk Inc $259.26 3 $0 (2024)
NeoTract Inc. $122.73 1 $0 (2017)
Regeneron Healthcare Solutions, Inc. $118.97 1 $0 (2024)
CSL Behring $44.63 2 $0 (2020)
PFIZER INC. $19.52 1 $0 (2018)
E.R. Squibb & Sons, L.L.C. $14.55 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $375.08 4 Novo Nordisk Inc ($135.24)
2023 $5,124 2 Merck Sharp & Dohme LLC ($5,000)
2020 $22.82 1 CSL Behring ($22.82)
2019 $161.33 3 Merck Sharp & Dohme Corporation ($114.70)
2018 $166.33 3 Amgen Inc. ($125.00)
2017 $238.91 2 NeoTract Inc. ($122.73)

All Payment Transactions

15 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
11/01/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $17.95 General
Category: Diabetes
09/04/2024 Amgen Inc. EVENITY (Biological) Food and Beverage In-kind items and services $120.87 General
Category: Bone Health
04/10/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $118.97 General
Category: INFLAMMATION AND IMMUNOLOGY
01/10/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $117.29 General
Category: Obesity
04/25/2023 Novo Nordisk Inc Food and Beverage In-kind items and services $124.02 General
02/13/2023 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $5,000.00 General
06/15/2020 CSL Behring Haegarda (Biological), Kcentra Food and Beverage In-kind items and services $22.82 General
Category: Immunology
10/31/2019 Amgen Inc. Aimovig (Biological) Food and Beverage In-kind items and services $32.08 General
Category: Neuroscience
06/03/2019 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $14.55 General
Category: Cardiovascular
01/10/2019 Merck Sharp & Dohme Corporation GARDASIL (Biological) Food and Beverage In-kind items and services $114.70 General
Category: VACCINE
12/18/2018 PFIZER INC. SURGISEAL (Device) Food and Beverage In-kind items and services $19.52 General
Category: HEMOSTAT
10/17/2018 Amgen Inc. Prolia (Biological) Food and Beverage In-kind items and services $125.00 General
Category: Endocrinology
10/10/2018 CSL Behring Kcentra (Biological) Food and Beverage In-kind items and services $21.81 General
Category: Trauma (Emergency, Injury, Surgery)
09/19/2017 NeoTract Inc. Urolift - UL400 (Device) Food and Beverage In-kind items and services $122.73 General
Category: Urology
02/08/2017 Merck Sharp & Dohme Corporation SIVEXTRO (Drug) Food and Beverage In-kind items and services $116.18 General
Category: INFECTIOUS DISEASE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 114 114 $39,342 $7,389
2022 3 82 82 $33,091 $6,432
2020 2 29 30 $13,017 $2,798
Total Patients
225
Total Services
226
Medicare Billing
$16,619
Procedure Codes
9

All Medicare Procedures & Services

9 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 44 44 $19,316 $3,304 17.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 26 26 $16,094 $2,662 16.5%
87635 Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen Office 2023 28 28 $3,676 $1,369 37.2%
81002 Urinalysis, manual test Office 2023 16 16 $256.00 $54.56 21.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 32 32 $14,112 $2,595 18.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 19 19 $11,818 $2,276 19.3%
87635 Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen Office 2022 31 31 $7,161 $1,561 21.8%
99285 Emergency department visit, problem with significant threat to life or function Facility 2020 17 17 $12,235 $2,701 22.1%
93010 Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report Facility 2020 12 13 $782.00 $96.30 12.3%

About Dr. Sherry Yafai, M.D

Dr. Sherry Yafai, M.D is a Personal Emergency Response Attendant healthcare provider based in Santa Monica, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2008. The National Provider Identifier (NPI) number assigned to this provider is 1366628471.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sherry Yafai, M.D has received a total of $6,088 in payments from pharmaceutical and medical device companies, with $375.08 received in 2024. These payments were reported across 15 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($5,000).

As a Medicare-enrolled provider, Yafai has provided services to 225 Medicare beneficiaries, totaling 226 services with total Medicare billing of $16,619. Data is available for 3 years (2020–2023), covering 9 distinct procedure/service records.

Practice Information

  • Specialty Personal Emergency Response Attendant
  • Other Specialties Emergency Medicine
  • Location Santa Monica, CA
  • Active Since 01/18/2008
  • Last Updated 06/26/2021
  • Taxonomy Code 146D00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1366628471

Products in Payments

  • Prolia (Biological) $125.00
  • Urolift - UL400 (Device) $122.73
  • EVENITY (Biological) $120.87
  • DUPIXENT (Biological) $118.97
  • Wegovy (Drug) $117.29
  • SIVEXTRO (Drug) $116.18
  • GARDASIL (Biological) $114.70
  • Aimovig (Biological) $32.08
  • Haegarda (Biological) $22.82
  • Kcentra (Biological) $21.81
  • SURGISEAL (Device) $19.52
  • Rybelsus (Drug) $17.95
  • ELIQUIS (Drug) $14.55

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.